Global Pneumococcal Vaccine Market Growth 2021-2026

  • receipt Report ID : 239003
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 134
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Pneumococcal Vaccine will have significant change from previous year. By the most conservative estimates of global Pneumococcal Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 6966.9 million in 2020. Over the next five years the Pneumococcal Vaccine market will register a 1.1% CAGR in terms of revenue, the global market size will reach US$ 7290.4 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

PPSV 23

PCV 7/13

PCV 10

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Child

Adult

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Pfizer

GSK

MSD

Sanofipasteur

CDIBP

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pneumococcal Vaccine Consumption 2016-2026

2.1.2 Pneumococcal Vaccine Consumption CAGR by Region

2.2 Pneumococcal Vaccine Segment by Type

2.2.1 PPSV 23

2.2.2 PCV 7/13

2.2.3 PCV 10

2.3 Pneumococcal Vaccine Sales by Type

2.3.1 Global Pneumococcal Vaccine Sales Market Share by Type (2016-2021)

2.3.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2016-2021)

2.3.3 Global Pneumococcal Vaccine Sale Price by Type (2016-2021)

2.4 Pneumococcal Vaccine Segment by Application

2.4.1 Child

2.4.2 Adult

2.5 Pneumococcal Vaccine Sales by Application

2.5.1 Global Pneumococcal Vaccine Sale Market Share by Application (2016-2021)

2.5.2 Global Pneumococcal Vaccine Revenue and Market Share by Application (2016-2021)

2.5.3 Global Pneumococcal Vaccine Sale Price by Application (2016-2021)

3 Global Pneumococcal Vaccine by Company

3.1 Global Pneumococcal Vaccine Sales Market Share by Company

3.1.1 Global Pneumococcal Vaccine Sales by Company (2019-2021)

3.1.2 Global Pneumococcal Vaccine Sales Market Share by Company (2019-2021)

3.2 Global Pneumococcal Vaccine Revenue Market Share by Company

3.2.1 Global Pneumococcal Vaccine Revenue by Company (2019-2021)

3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2021)

3.3 Global Pneumococcal Vaccine Sale Price by Company

3.4 Global Manufacturers Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pneumococcal Vaccine Product Location Distribution

3.4.2 Players Pneumococcal Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Pneumococcal Vaccine by Region

4.1 Global Pneumococcal Vaccine by Region

4.1.1 Global Pneumococcal Vaccine Sales by Region

4.1.2 Global Pneumococcal Vaccine Revenue by Region

4.2 Americas Pneumococcal Vaccine Sales Growth

4.3 APAC Pneumococcal Vaccine Sales Growth

4.4 Europe Pneumococcal Vaccine Sales Growth

4.5 Middle East & Africa Pneumococcal Vaccine Sales Growth

5 Americas

5.1 Americas Pneumococcal Vaccine Sales by Country

5.1.1 Americas Pneumococcal Vaccine Sales by Country (2016-2021)

5.1.2 Americas Pneumococcal Vaccine Revenue by Country (2016-2021)

5.2 Americas Pneumococcal Vaccine Sales by Type

5.3 Americas Pneumococcal Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pneumococcal Vaccine Sales by Region

6.1.1 APAC Pneumococcal Vaccine Sales by Region (2016-2021)

6.1.2 APAC Pneumococcal Vaccine Revenue by Region (2016-2021)

6.2 APAC Pneumococcal Vaccine Sales by Type

6.3 APAC Pneumococcal Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Pneumococcal Vaccine by Country

7.1.1 Europe Pneumococcal Vaccine Sales by Country (2016-2021)

7.1.2 Europe Pneumococcal Vaccine Revenue by Country (2016-2021)

7.2 Europe Pneumococcal Vaccine Sales by Type

7.3 Europe Pneumococcal Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pneumococcal Vaccine by Country

8.1.1 Middle East & Africa Pneumococcal Vaccine Sales by Country (2016-2021)

8.1.2 Middle East & Africa Pneumococcal Vaccine Revenue by Country (2016-2021)

8.2 Middle East & Africa Pneumococcal Vaccine Sales by Type

8.3 Middle East & Africa Pneumococcal Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Pneumococcal Vaccine Distributors

10.3 Pneumococcal Vaccine Customer

11 Global Pneumococcal Vaccine Market Forecast

11.1 Global Pneumococcal Vaccine Forecast by Region

11.1.1 Global Pneumococcal Vaccine Forecast by Regions (2021-2026)

11.2.2 Global Pneumococcal Vaccine Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Pneumococcal Vaccine Forecast by Type

11.7 Global Pneumococcal Vaccine Forecast by Application

12 Key Players Analysis

12.1 Pfizer

12.1.1 Pfizer Company Information

12.1.2 Pfizer Pneumococcal Vaccine Product Offered

12.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Pfizer Main Business Overview

12.1.5 Pfizer Latest Developments

12.2 GSK

12.2.1 GSK Company Information

12.2.2 GSK Pneumococcal Vaccine Product Offered

12.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 GSK Main Business Overview

12.2.5 GSK Latest Developments

12.3 MSD

12.3.1 MSD Company Information

12.3.2 MSD Pneumococcal Vaccine Product Offered

12.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 MSD Main Business Overview

12.3.5 MSD Latest Developments

12.4 Sanofipasteur

12.4.1 Sanofipasteur Company Information

12.4.2 Sanofipasteur Pneumococcal Vaccine Product Offered

12.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Sanofipasteur Main Business Overview

12.4.5 Sanofipasteur Latest Developments

12.5 CDIBP

12.5.1 CDIBP Company Information

12.5.2 CDIBP Pneumococcal Vaccine Product Offered

12.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 CDIBP Main Business Overview

12.5.5 CDIBP Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Pneumococcal Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of PPSV 23

Table 3. Major Players of PCV 7/13

Table 4. Major Players of PCV 10

Table 5. Global Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)

Table 6. Global Pneumococcal Vaccine Sales Market Share by Type (2016-2021)

Table 7. Global Pneumococcal Vaccine Revenue by Type (2016-2021) & ($ million)

Table 8. Global Pneumococcal Vaccine Revenue Market Share by Type (2016-2021)

Table 9. Global Pneumococcal Vaccine Sale Price by Type (2016-2021)

Table 10. Global Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)

Table 11. Global Pneumococcal Vaccine Sales Market Share by Application (2016-2021)

Table 12. Global Pneumococcal Vaccine Value by Application (2016-2021)

Table 13. Global Pneumococcal Vaccine Revenue Market Share by Application (2016-2021)

Table 14. Global Pneumococcal Vaccine Sale Price by Application (2016-2021)

Table 15. Global Pneumococcal Vaccine Sales by Company (2019-2021) & (K Doses)

Table 16. Global Pneumococcal Vaccine Sales Market Share by Company (2019-2021)

Table 17. Global Pneumococcal Vaccine Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Pneumococcal Vaccine Revenue Market Share by Company (2019-2021)

Table 19. Global Pneumococcal Vaccine Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Pneumococcal Vaccine Producing Area Distribution and Sales Area

Table 21. Players Pneumococcal Vaccine Products Offered

Table 22. Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Pneumococcal Vaccine Sales by Region (2016-2021) (K Doses)

Table 26. Global Pneumococcal Vaccine Sales Market Share by Region (2016-2021)

Table 27. Global Pneumococcal Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)

Table 29. Americas Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses)

Table 30. Americas Pneumococcal Vaccine Sales Market Share by Country (2016-2021)

Table 31. Americas Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)

Table 33. Americas Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)

Table 34. Americas Pneumococcal Vaccine Sales Market Share by Type (2016-2021)

Table 35. Americas Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)

Table 36. Americas Pneumococcal Vaccine Sales Market Share by Application (2016-2021)

Table 37. APAC Pneumococcal Vaccine Sales by Region (2016-2021) & (K Doses)

Table 38. APAC Pneumococcal Vaccine Sales Market Share by Region (2016-2021)

Table 39. APAC Pneumococcal Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)

Table 41. APAC Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)

Table 42. APAC Pneumococcal Vaccine Sales Market Share by Type (2016-2021)

Table 43. APAC Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)

Table 44. APAC Pneumococcal Vaccine Sales Market Share by Application (2016-2021)

Table 45. Europe Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses)

Table 46. Europe Pneumococcal Vaccine Sales Market Share by Country (2016-2021)

Table 47. Europe Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)

Table 49. Europe Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)

Table 50. Europe Pneumococcal Vaccine Sales Market Share by Type (2016-2021)

Table 51. Europe Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)

Table 52. Europe Pneumococcal Vaccine Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Pneumococcal Vaccine Sales by Country (2016-2021) & (K Doses)

Table 54. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Pneumococcal Vaccine Sales by Type (2016-2021) & (K Doses)

Table 58. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Pneumococcal Vaccine Sales by Application (2016-2021) & (K Doses)

Table 60. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Application (2016-2021)

Table 61. Key and Potential Regions of Pneumococcal Vaccine

Table 62. Key Application and Potential Industries of Pneumococcal Vaccine

Table 63. Key Challenges of Pneumococcal Vaccine

Table 64. Key Trends of Pneumococcal Vaccine

Table 65. Pneumococcal Vaccine Distributors List

Table 66. Pneumococcal Vaccine Customer List

Table 67. Global Pneumococcal Vaccine Sales Forecast by Region (2021-2026) & (K Doses)

Table 68. Global Pneumococcal Vaccine Consumption Market Forecast by Region

Table 69. Global Pneumococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 70. Global Pneumococcal Vaccine Revenue Market Share Forecast by Region (2021-2026)

Table 71. Americas Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Doses)

Table 72. Americas Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 73. APAC Pneumococcal Vaccine Sales Forecast by Region (2021-2026) & (K Doses)

Table 74. APAC Pneumococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 75. Europe Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Doses)

Table 76. Europe Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 77. Middle East & Africa Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Doses)

Table 78. Middle East & Africa Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Global Pneumococcal Vaccine Sales Forecast by Type (2021-2026) & (K Doses)

Table 80. Global Pneumococcal Vaccine Sales Market Share Forecast by Type (2021-2026)

Table 81. Global Pneumococcal Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 82. Global Pneumococcal Vaccine Revenue Market Share Forecast by Type (2021-2026)

Table 83. Global Pneumococcal Vaccine Sales Forecast by Application (2021-2026) & (K Doses)

Table 84. Global Pneumococcal Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 85. Global Pneumococcal Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 86. Global Pneumococcal Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 87. Pfizer Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 88. Pfizer Pneumococcal Vaccine Product Offered

Table 89. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 90. Pfizer Main Business

Table 91. Pfizer Latest Developments

Table 92. GSK Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. GSK Pneumococcal Vaccine Product Offered

Table 94. GSK Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 95. GSK Main Business

Table 96. GSK Latest Developments

Table 97. MSD Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. MSD Pneumococcal Vaccine Product Offered

Table 99. MSD Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 100. MSD Main Business

Table 101. MSD Latest Developments

Table 102. Sanofipasteur Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofipasteur Pneumococcal Vaccine Product Offered

Table 104. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 105. Sanofipasteur Main Business

Table 106. Sanofipasteur Latest Developments

Table 107. CDIBP Basic Information, Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. CDIBP Pneumococcal Vaccine Product Offered

Table 109. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 110. CDIBP Main Business

Table 111. CDIBP Latest Developments

List of Figures

Figure 1. Picture of Pneumococcal Vaccine

Figure 2. Pneumococcal Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pneumococcal Vaccine Sales Growth Rate 2016-2026 (K Doses)

Figure 7. Global Pneumococcal Vaccine Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Pneumococcal Vaccine Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of PPSV 23

Figure 10. Product Picture of PCV 7/13

Figure 11. Product Picture of PCV 10

Figure 12. Global Pneumococcal Vaccine Sales Market Share by Type in 2020

Figure 13. Global Pneumococcal Vaccine Revenue Market Share by Type (2016-2021)

Figure 14. Pneumococcal Vaccine Consumed in Child

Figure 15. Global Pneumococcal Vaccine Market: Child (2016-2021) & (K Doses)

Figure 16. Pneumococcal Vaccine Consumed in Adult

Figure 17. Global Pneumococcal Vaccine Market: Adult (2016-2021) & (K Doses)

Figure 18. Global Pneumococcal Vaccine Sales Market Share by Application (2016-2021)

Figure 19. Global Pneumococcal Vaccine Revenue Market Share by Application in 2020

Figure 20. Pneumococcal Vaccine Revenue Market by Company in 2020 ($ Million)

Figure 21. Global Pneumococcal Vaccine Revenue Market Share by Company in 2020

Figure 22. Global Pneumococcal Vaccine Sales Market Share by Regions (2016-2021)

Figure 23. Global Pneumococcal Vaccine Revenue Market Share by Region in 2020

Figure 24. Americas Pneumococcal Vaccine Sales 2016-2021 (K Doses)

Figure 25. Americas Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)

Figure 26. APAC Pneumococcal Vaccine Sales 2016-2021 (K Doses)

Figure 27. APAC Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)

Figure 28. Europe Pneumococcal Vaccine Sales 2016-2021 (K Doses)

Figure 29. Europe Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)

Figure 30. Middle East & Africa Pneumococcal Vaccine Sales 2016-2021 (K Doses)

Figure 31. Middle East & Africa Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)

Figure 32. Americas Pneumococcal Vaccine Sales Market Share by Country in 2020

Figure 33. Americas Pneumococcal Vaccine Revenue Market Share by Country in 2020

Figure 34. Americas Pneumococcal Vaccine Sales Market Share by Type in 2020

Figure 35. Americas Pneumococcal Vaccine Sales Market Share by Application in 2020

Figure 36. United States Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 37. Canada Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 38. Mexico Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 39. Brazil Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 40. APAC Pneumococcal Vaccine Sales Market Share by Region in 2020

Figure 41. APAC Pneumococcal Vaccine Revenue Market Share by Regions in 2020

Figure 42. APAC Pneumococcal Vaccine Sales Market Share by Type in 2020

Figure 43. APAC Pneumococcal Vaccine Sales Market Share by Application in 2020

Figure 44. China Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 45. Japan Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 46. Korea Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 47. Southeast Asia Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 48. India Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 49. Australia Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 50. Europe Pneumococcal Vaccine Sales Market Share by Country in 2020

Figure 51. Europe Pneumococcal Vaccine Revenue Market Share by Country in 2020

Figure 52. Europe Pneumococcal Vaccine Sales Market Share by Type in 2020

Figure 53. Europe Pneumococcal Vaccine Sales Market Share by Application in 2020

Figure 54. Germany Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 55. France Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 56. UK Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 57. Italy Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 58. Russia Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 59. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Country in 2020

Figure 60. Middle East & Africa Pneumococcal Vaccine Revenue Market Share by Country in 2020

Figure 61. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Type in 2020

Figure 62. Middle East & Africa Pneumococcal Vaccine Sales Market Share by Application in 2020

Figure 63. Egypt Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 64. South Africa Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 65. Israel Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 66. Turkey Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 67. GCC Country Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery